AER 1487663, is a spontaneous case received on 06/Nov/2014, from a physician via company representative and 
concerns a female patient of unspecified age who experienced progressive multifocal leukoencephalopathy (PML) 
and died while been treated with rituximab.
No medical history, concurrent conditions, concomitant medications or past drugs were reported.
On an unspecified date, the patient started therapy with rituximab (route, dose, form, frequency not reported) for 
unknown indication. In 2007, she experienced progressive multifocal leukoencephalopathy (PML) and subsequently
died on an unspecified date. There was insufficient information regarding the autopsy.
At the time of death therapy status of rituximab was unknown.
The reporter did not assess the causality of fatal progressive multifocal leukoencephalopathy (PML) to rituximab.
Print Time: 24-MAY-2016 07:56 AM If a field is blank, there is no data for that field Page 554 of 570
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
No further information was provided.